CaviWipes™ HP

CaviWipes HP surface disinfectant offers a 1-minute universal contact time against 67 listed pathogens, utilizing a hydrogen peroxide formulation that meets all levels of the EPA’s rigorous Emerging Viral Pathogen Claim (EPA List Q)*, including enveloped viruses, small non-enveloped viruses, and large non-enveloped viruses. The High-Performance disinfection protocol of CaviWipes HP disinfecting wipes helps protect both patients and staff.

Request a Sample

Features & Benefits

CaviWipes HP offers a universal 1-minute contact time against all listed pathogens, offering simplicity and peace of mind for every application. The new green top opens and closes more easily and securely, and dispenses wipes with precision, helping to reduce waste.

CaviWipes HP provides a friendly alternative for those who prefer not to use alcohol-based wipes, and our HP formulation provides better cleaning efficacy than alcohol-based products.**

Our 1-step*** and 1-minute universal contact time reduces waiting time for disinfection and increases staff efficiency.

In addition to providing effective disinfection against all 67 listed pathogens including MDRO’s, CaviWipes HP is qualified for the EPA’s rigorous Emerging Viral Pathogen claim, helping protect you against future pathogens as well.

_{*List Q: Disinfectants for Emerging Virap Pathogens (EVPs),}
_{www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q}
_{**Data on file.}
_{***Precleaning is required when visibly soiled and/or disinfecting against}_{Candida auris}_{, HIV, HBV and HCV.}

Kill Claims

Mycobacterium

Mycobacterium tuberculosis var: bovis (BCG)

Viruses (Non-Enveloped)

Human Norovirus
Human Rotavirus
Rhinovirus Type 37
Rhinovirus Type 1A
Human Adenovirus Type 5
Echovirus Type 11
Enterovirus Type 71

Viruses (Enveloped)

Herpes simplex virus Type 1 & Type 2
Avian Influenza A virus (H7N9)
Avian Influenza A virus (H5N1)
Influenza A virus (H3N2)
Influenza B virus (H1N1)
Parainfluenza virus Type 3
Hepatitis B virus (HBV)
Human Hepatitis C virus (HCV)
Human lmmunodeficiency virus Type 1 (HIV-1)
Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)
Vaccinia virus
SARS-Associated Coronavirus (SARs-CoV)
Cytomegalovirus (CMV)
Influenza A virus (H1N1) Strains A/4108/2009 and A/04/09
Human Coronavirus
Respiratory Syncytial Virus (RSV)
Measles virus

Pathogenic Fungi

Trichophyton interdigitale
Candida auris
Candida albicans

Bacteria

Pseudomonas aeruginosa
Staphylococcus aureus
Salmonella enterica
Bordetella pertussis
Enterococcus faecium
Klebsiella aerogenes
Klebsiella pneumoniae
Escherichia coli
Escherichia coli O157:H7
Burkholderia cepacia
Stenotrophomonas maltophilia
Streptococcus pyogenes
Listeria monocytogenes
Shigella dysenteriae
Serratia marcescens
Bordetella bronchiseptica
Campylobacter jejuni
Proteus vulgaris

Multi-Drug-Resistant Bacteria (MDRO)

Penicillin-Resistant Streptococcus pneumoniae (PRSP)
Vancomycin-Resistant Enterococcus faecalis (VRE)
Methicillin-Resistant Staphylococcus aureus (MRSA)
Hospital-Acquired and Community Acquired Methicillin-Resistant
Staphylococcus aureus (HA-MRSA and CA-MRSA)
Vancomycin Intermediate Staphylococcus aureus (VISA)
Vancomycin Resistant Staphylococcus aureus (VRSA)
Linezolid-Resistant Staphylococcus aureus (LRSA)
Carbapenem-Resistant Klebsiella pneumoniae
Multidrug-Resistant Acinetobacter baumannii (MRAB) Strains
ATCC 19606 and ATCC BAA-1605
NDM-1 Enterobacter cloacae
NDM-1 Klebsiella pneumoniae
MBL Pseudomonas aeruginosa
NMD-1 Escherichia coli
ESBL Klebsiella pneumoniae
ESBL Escherichia coli
Multidrug-Resistant Klebsiella pneumoniae
Carbapenem-Resistant Escherichia coli